Pulmonary Hypertension Trial, Recruiting NCT05841615 Sponsor: The First Affiliated Hospital of Xiamen University Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT05841615
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • People whose blood pressure readings are high — either at least 140/90 mmHg in a clinic setting, or an average of at least 135/85 mmHg over a 24-hour monitoring period
  • People whose ECG (heart tracing) shows a heart rhythm condition called atrial fibrillation
  • People who have given written consent to participate and whose involvement has been approved by the Ethics Committee of the First Affiliated Hospital of Xiamen University

Who may not be able to join:

  • People who are pregnant or currently breastfeeding
  • People whose kidney arteries are found to be unsuitable for the procedure before surgery — for example, if there is significant narrowing of the artery (more than 50%), an aneurysm, a previous procedure on the kidney artery, an abnormal artery structure, or if the artery is too small or too short to treat
  • People who have only one kidney or have had a kidney transplant
  • People who have previously had a procedure on their kidney arteries or a nerve-blocking procedure around the kidney arteries
  • People with a confirmed type of high blood pressure caused by something other than kidney tissue disease (confirm with trial site)
  • People with a cancer diagnosis or an end-stage (advanced, life-limiting) illness
  • People with severe disease of the blood vessels in the limbs, or an enlarged aorta in the abdomen (abdominal aortic aneurysm)
  • People whose left heart chamber (left atrium) measures larger than 55mm
  • People with a notable tendency to bleed or a diagnosed blood disorder
  • People who have had an acute coronary syndrome (such as a heart attack or severe chest pain episode) within the past two weeks
  • People with a current acute or serious infection affecting the whole body
  • People with dependence on drugs or alcohol, or who are unwilling to sign the consent form
  • People who have other conditions that make them unsuitable for the two procedures involved in this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The First Affiliated Hospital of Xiamen University
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
30 April 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Malignant end point event 1; Malignant end point event 2; Malignant end point event 3; Malignant end point event 4

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov